MONTVALE, N.J., April 18 /PRNewswire-FirstCall/ -- Memory Pharmaceuticals
Corp. (Nasdaq: MEMY) today announced that Jim Sulat, President and Chief
Executive Officer, will provide a company update at the 7th Annual Fortis
Biotech Conference on Wednesday, April 25, 2007, at 11:15 a.m. British Summer
Time (6.15 a.m. Eastern Daylight Time). The conference is being held at the
Four Seasons Hotel, Park Lane, London.
Interested parties may access the live webcast of the presentation by
visiting the "Investors" section of Memory Pharmaceuticals' website at
http://www.memorypharma.com. Archived versions of the webcast will be
available at the same location for one week following the presentation.
About the Company
Memory Pharmaceuticals Corp., a biopharmaceutical company, is focused on
developing innovative drugs for the treatment of debilitating CNS disorders
such as Alzheimer's disease, schizophrenia, depression and bipolar disorder.
For additional information, please visit our website at
http://www.memorypharma.com.
SOURCE Memory Pharmaceuticals Corp.
-0- 04/18/2007
/CONTACT: Jzaneen Lalani, General Counsel/Investor Relations of Memory
Pharmaceuticals Corp., +1-201-802-7249; or Laura Perry of Stern Investor
Relations, Inc., +1-212-362-1200, for Memory Pharmaceuticals Corp./
/Web site: http://www.memorypharma.com/
(MEMY)
CO: Memory Pharmaceuticals Corp.
ST: New Jersey, England
IN: HEA BIO MTC
SU: CCA TDS
CA-MJ
-- NYW121 --
9334 04/18/2007 14:06 EDT http://www.prnewswire.com
